$721M
$836,000
0.0% of portfolio
6,444
Q3 2024
Added 27.83%
$994M
$261,000
0.0% of portfolio
12,157
Q3 2024
Added 0.59%
$836M
$357,000
0.0% of portfolio
11,680
Q3 2024
Added 15.38%
$651M
$4.36 Million
0.0% of portfolio
82,922
Q3 2024
Added 44.8%
$1.07B
$5.71 Million
0.0% of portfolio
448,989
Q3 2024
Added 6.75%
$3.45B
$440,000
0.0% of portfolio
4,824
Q3 2024
Reduced 12.08%
$13.7B
$1.32 Million
0.0% of portfolio
33,857
Q3 2024
Reduced 55.3%
$886M
$13.9 Million
0.0% of portfolio
167,310
Q3 2024
Added 0.01%
$3.19B
$716,000
0.0% of portfolio
4,248
Q3 2024
Added 3.28%
$468M
$280,000
0.0% of portfolio
9,418
Q3 2024
New
$893M
$4.27 Million
0.0% of portfolio
384,054
Q3 2024
Added 32.39%
$7.4B
$7.36 Million
0.0% of portfolio
52,911
Q3 2024
Added 1.83%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 61.49%
$464M
$1.11 Million
0.0% of portfolio
39,042
Q3 2024
New
$772M
$15.1 Million
0.0% of portfolio
247,044
Q3 2024
Reduced 11.61%
$1.69B
$988,000
0.0% of portfolio
39,928
Q3 2024
Added 5.63%
$1.07B
$3.55 Million
0.0% of portfolio
600,012
Q3 2024
Reduced 3.02%
$2.51B
$3.69 Million
0.0% of portfolio
47,847
Q3 2024
Added 21.09%
Mineralys Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 17.73%
Mirum Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.72%
$508M
$228,000
0.0% of portfolio
26,274
Q3 2024
Added 2.73%
$143B
$500,000
0.0% of portfolio
49,208
Q3 2024
Added 1.94%
$62.1B
$230,000
0.0% of portfolio
55,231
Q3 2024
Added 12.64%
$7.11B
$2.53 Million
0.0% of portfolio
23,311
Q3 2024
Added 26.24%
$15.8B
$2.05 Million
0.0% of portfolio
30,743
Q3 2024
Reduced 64.7%
$155M
$1.11 Million
0.0% of portfolio
77,907
Q3 2024
Reduced 5.16%
$4.6B
$268,000
0.0% of portfolio
3,913
Q3 2024
Added 0.9%
$7.6B
$5.97 Million
0.0% of portfolio
37,162
Q3 2024
Added 32.77%
$17.2B
$2.8 Million
0.0% of portfolio
8,137
Q3 2024
Reduced 72.4%
$1.49B
$699,000
0.0% of portfolio
8,822
Q3 2024
Added 7.26%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 96.6%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 65.81%
Morgan Stanley Direct Lendin
-
$0
0.0% of portfolio
-
Q3 2024
New
$14.5B
$473,000
0.0% of portfolio
1,483
Q3 2024
Reduced 23.44%
$8.31B
$8.04 Million
0.0% of portfolio
300,338
Q3 2024
Added 30.26%
$2.99B
$3.15 Million
0.0% of portfolio
178,444
Q3 2024
Added 0.07%
$47.9B
$942,000
0.0% of portfolio
21,210
Q3 2022
Reduced 3.37%
$6.76B
$6.9 Million
0.0% of portfolio
74,847
Q3 2024
Reduced 4.6%
$1.08B
$958,000
0.0% of portfolio
75,236
Q2 2024
Added 35.43%
$6.59B
$2.62 Million
0.0% of portfolio
14,777
Q3 2024
Reduced 54.72%
$3.6B
$3.6 Million
0.0% of portfolio
41,903
Q3 2024
Reduced 20.33%
$4.61B
$5.12 Million
0.0% of portfolio
69,102
Q3 2024
Added 6.73%
$4.46B
$3.01 Million
0.0% of portfolio
89,188
Q3 2024
Reduced 2.35%
$417M
$322,000
0.0% of portfolio
23,343
Q3 2024
Added 0.46%
$1.09B
$1.59 Million
0.0% of portfolio
58,055
Q3 2024
Added 8.83%
$1.73B
$143,000
0.0% of portfolio
10,968
Q3 2024
Reduced 0.06%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.3%
$481M
$387,000
0.0% of portfolio
6,017
Q3 2024
Reduced 12.35%
$393M
$142,000
0.0% of portfolio
23,366
Q3 2024
New
$1.33B
$807,000
0.0% of portfolio
19,961
Q3 2024
Added 4.8%